Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (751-760 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|May 6, 2014
Advanced prostate cancer is distinguished by cholesteryl ester accumulation
Cancer Discovery|May 6, 2014
Paths of resistance to EGFR inhibitors: is NF enough?Ophélia Maertens, Karen Cichowski
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Cancer Discovery|May 6, 2014
Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL
Cancer Discovery|May 6, 2014
Angiogenesis-related gene mutations drive a subset of angiosarcomas
Cancer Discovery|May 6, 2014
SAICAR binding activates PKM2 protein kinase activity
Cancer Discovery|February 15, 2017
Universal CAR T Cells Treat Leukemia
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
Cancer Discovery|March 14, 2019
Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate TumorsPatrick A Ott, Catherine J Wu
Cancer Discovery|August 10, 2019
Vaccine Increases PFS for Metastatic Tumors
Pageof 427

Showing results (751-760 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|May 6, 2014
Advanced prostate cancer is distinguished by cholesteryl ester accumulation
Cancer Discovery|May 6, 2014
Paths of resistance to EGFR inhibitors: is NF enough?Ophélia Maertens, Karen Cichowski
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Cancer Discovery|May 6, 2014
Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL
Cancer Discovery|May 6, 2014
Angiogenesis-related gene mutations drive a subset of angiosarcomas
Cancer Discovery|May 6, 2014
SAICAR binding activates PKM2 protein kinase activity
Cancer Discovery|February 15, 2017
Universal CAR T Cells Treat Leukemia
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
Cancer Discovery|March 14, 2019
Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate TumorsPatrick A Ott, Catherine J Wu
Cancer Discovery|August 10, 2019
Vaccine Increases PFS for Metastatic Tumors
Pageof 427